Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC (PET Boost)

This study has suspended participant recruitment.
(safety issue)
European Union
Information provided by (Responsible Party):
The Netherlands Cancer Institute Identifier:
First received: December 1, 2009
Last updated: October 8, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):